Interest Expense of Vitro Biopharma, Inc. from 31 Jul 2010 to 30 Apr 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Vitro Biopharma, Inc. quarterly and annual Interest Expense in USD history and change rate from 31 Jul 2010 to 30 Apr 2024.
  • Vitro Biopharma, Inc. Interest Expense for the quarter ending 30 Apr 2024 was $2,160,299, a 3694% increase year-over-year.
  • Vitro Biopharma, Inc. Interest Expense for the twelve months ending 30 Apr 2024 was $2,505,480, a 1345% increase year-over-year.
  • Vitro Biopharma, Inc. annual Interest Expense for 2023 was $270,182, a 36% increase from 2022.
  • Vitro Biopharma, Inc. annual Interest Expense for 2022 was $198,450.
  • Vitro Biopharma, Inc. annual Interest Expense for 2015 was $87,732, a 16% increase from 2014.
Source SEC data
View on sec.gov
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Vitro Biopharma, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $2,505,480 $2,160,299 +$2,103,362 +3694% 01 Feb 2024 30 Apr 2024 10-Q 31 May 2024 2024 Q2
Q4 2023 $402,118 $171,629 +$131,936 +332% 01 Nov 2023 31 Jan 2024 10-Q 14 Mar 2024 2024 Q1
Q3 2023 $270,182 $91,576 +$52,823 +136% 01 Aug 2023 31 Oct 2023 10-K 29 Jan 2024 2023 FY
Q2 2023 $217,359 $81,976 +$43,982 +116% 01 May 2023 31 Jul 2023 10-Q 28 Aug 2023 2023 Q3
Q1 2023 $173,377 $56,937 +$9,967 +21% 01 Feb 2023 30 Apr 2023 10-Q 31 May 2024 2024 Q2
Q4 2022 $163,410 $39,693 -$35,040 -47% 01 Nov 2022 31 Jan 2023 10-Q 14 Mar 2024 2024 Q1
Q3 2022 $198,450 $38,753 01 Aug 2022 31 Oct 2022 10-K 29 Jan 2024 2023 FY
Q2 2022 $37,994 01 May 2022 31 Jul 2022 10-Q 28 Aug 2023 2023 Q3
Q1 2022 $46,970 01 Feb 2022 30 Apr 2022 10-Q 13 Jun 2023 2023 Q2
Q4 2021 $74,733 01 Nov 2021 31 Jan 2022 10-Q 14 Mar 2023 2023 Q1
Q1 2015 $69,670 $21,710 -$2,865 -15% 01 Feb 2015 30 Apr 2015 10-Q 22 Jan 2016 2015 Q2
Q4 2014 $72,535 $20,601 -$2,951 -17% 01 Nov 2014 31 Jan 2015 10-Q 24 Mar 2015 2015 Q1
Q3 2014 $75,486 $131,046 01 Aug 2014 31 Oct 2014 10-K 22 Sep 2016 2015 FY
Q2 2014 $19,065 -$3,714 -24% 01 May 2014 31 Jul 2014 10-Q 22 Sep 2014 2014 Q3
Q1 2014 $18,845 -$33,607 -228% 01 Feb 2014 30 Apr 2014 10-Q 22 Jan 2016 2015 Q2
Q4 2013 $17,650 01 Nov 2013 31 Jan 2014 10-Q 24 Mar 2015 2015 Q1
Q2 2013 $15,351 -$27,984 -222% 01 May 2013 31 Jul 2013 10-Q 22 Sep 2014 2014 Q3
Q1 2013 $14,762 +$26,713 01 Feb 2013 30 Apr 2013 10-Q 19 Jun 2014 2014 Q2
Q3 2012 $48,512 $58,436 +$88,219 01 Aug 2012 31 Oct 2012 10-K 12 Feb 2014 2013 FY
Q2 2012 $39,707 $12,633 +$2,702 +27% 01 May 2012 31 Jul 2012 10-Q/A 17 Oct 2012 2012 Q3
Q1 2012 $42,409 $11,951 -$1,560 -15% 01 Feb 2012 30 Apr 2012 10-Q/A 22 Jun 2012 2012 Q2
Q4 2011 $40,849 $10,606 +$2 +0.02% 01 Nov 2011 31 Jan 2012 10-Q 21 Mar 2012 2012 Q1
Q3 2011 $40,851 $29,783 01 Aug 2011 31 Oct 2011 10-K/A 16 Feb 2012 2011 FY
Q2 2011 $9,931 +$20,304 01 May 2011 31 Jul 2011 10-Q/A 17 Oct 2012 2012 Q3
Q1 2011 $10,391 01 Feb 2011 30 Apr 2011 10-Q/A 22 Jun 2012 2012 Q2
Q4 2010 $10,608 01 Nov 2010 31 Jan 2011 10-Q 21 Mar 2012 2012 Q1
Q2 2010 $10,373 01 May 2010 31 Jul 2010 10-Q/A 12 Oct 2011 2011 Q3

Vitro Biopharma, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $270,182 +$71,732 +36% 01 Nov 2022 31 Oct 2023 10-K 29 Jan 2024 2023 FY
2022 $198,450 01 Nov 2021 31 Oct 2022 10-K 29 Jan 2024 2023 FY
2015 $87,732 +$12,246 +16% 01 Nov 2014 31 Oct 2015 10-K 22 Sep 2016 2015 FY
2014 $75,486 +$135,370 01 Nov 2013 31 Oct 2014 10-K 22 Sep 2016 2015 FY
2013 $59,884 -$108,396 -223% 01 Nov 2012 31 Oct 2013 10-K 13 Feb 2015 2014 FY
2012 $48,512 +$89,363 01 Nov 2011 31 Oct 2012 10-K 12 Feb 2014 2013 FY
2011 $40,851 +$758 +1.8% 01 Nov 2010 31 Oct 2011 10-K/A 16 Feb 2012 2011 FY
2010 $41,609 01 Nov 2009 31 Oct 2010 10-K/A 16 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.